Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2026-08-31 18:45:25 ET · period of report 2026-08-27 · accession 0001737329-26-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-08-31 18:45 | 2026-08-27 | JAZZ | Iannone Robert | EVP, CMO, Gbl Head of R, D | M - OptEx | $125.84 | +57.5K | 142.6K | +68% | +$7.24M |
| DMT | 2026-08-31 18:45 | 2026-08-27 | JAZZ | Iannone Robert | EVP, CMO, Gbl Head of R, D | S - Sale+OE | $249.70 | -76.9K | 65.7K | -54% | -$19.21M |
| DMT | 2026-08-31 18:45 | 2026-08-27 | JAZZ | Iannone Robert | EVP, CMO, Gbl Head of R, D | M - OptEx | $0.00 | -57.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-08-27 | M | A | 26,116 | $113.10 | 111,223 | D | — | — | (F1) This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person. |
| 2 | Common | Ordinary Shares | 2026-08-27 | M | A | 884 | $113.10 | 112,107 | D | — | — | (F1) This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person. |
| 3 | Common | Ordinary Shares | 2026-08-27 | M | A | 27,584 | $137.12 | 139,691 | D | — | — | (F1) This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person. |
| 4 | Common | Ordinary Shares | 2026-08-27 | M | A | 2,916 | $137.12 | 142,607 | D | — | — | (F1) This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person. |
| 5 | Common | Ordinary Shares | 2026-08-27 | S | D | 18,187 | $247.86 | 124,420 | D | — | — | (F1) This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person. (F2) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $247.29 to $248.24. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 6 | Common | Ordinary Shares | 2026-08-27 | S | D | 11,423 | $248.67 | 112,997 | D | — | — | (F1) This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person. (F3) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $248.29 to $249.24. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 7 | Common | Ordinary Shares | 2026-08-27 | S | D | 18,113 | $250.02 | 94,884 | D | — | — | (F1) This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person. (F4) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $249.33 to $250.325 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 8 | Common | Ordinary Shares | 2026-08-27 | S | D | 19,639 | $250.60 | 75,245 | D | — | — | (F1) This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person. (F5) Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $250.33 to $251.29. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 9 | Common | Ordinary Shares | 2026-08-27 | S | D | 9,259 | $251.95 | 65,986 | D | — | — | (F1) This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person. (F6) Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $251.37 to $252.31. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 10 | Common | Ordinary Shares | 2026-08-27 | S | D | 300 | $252.76 | 65,686 | D | — | — | (F1) This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person. |
| 11 | Derivative | Incentive Stock Option (right to buy) | 2026-08-27 | M | D | 884 | $0.00 | 0 | D | $113.10 · — to 2030-02-26 | 884 Ordinary Shares | (F1) This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person. (F7) These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 27, 2020, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. |
| 12 | Derivative | Incentive Stock Option (right to buy) | 2026-08-27 | M | D | 2,916 | $0.00 | 0 | D | $137.12 · — to 2029-08-07 | 2,916 Ordinary Shares | (F1) This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person. (F8) These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of May 29, 2019, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter. |
| 13 | Derivative | Non-Qualified Stock Option (right to buy) | 2026-08-27 | M | D | 26,116 | $0.00 | 0 | D | $113.10 · — to 2030-02-26 | 26,116 Ordinary Shares | (F1) This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person. (F7) These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 27, 2020, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. |
| 14 | Derivative | Non-Qualified Stock Option (right to buy) | 2026-08-27 | M | D | 27,584 | $0.00 | 0 | D | $137.12 · — to 2029-08-07 | 27,584 Ordinary Shares | (F1) This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person. (F8) These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of May 29, 2019, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter. |